FOR IMMEDIATE RELEASE 

SYNDEO Medical, a Belgium based leader in diagnostic, interventional, and surgical procedural solutions, announces that the Clozex® wound closure system has secured new regulatory approvals across several strategically important global markets, including the Kingdom of Saudi Arabia, the Kingdom of Morocco, the Federative Republic of Brazil, and the Republic of India. These approvals form a major advancement in SYNDEO Medical’s global launch strategy and reflect the company’s deliberate approach to expanding access to advanced wound closure technologies in influential healthcare regions.

Over the past year, since first bringing Clozex to market, SYNDEO Medical has focused on registering the product in geographies that play a significant role in shaping healthcare standards, accelerating technology adoption, and influencing broader regional practice. The newly obtained approvals in Saudi Arabia, Morocco, Brazil, and India align with this strategy, positioning Clozex for long term growth and widespread clinical integration.

Clozex uses advanced wound closures with interlaced locking technology, enabling rapid, secure, and needle free skin approximation. Manufactured in the United States, it is recognised for consistent performance, fast application, and the ability to deliver clean, uniform wound closure. Its engineered tension distribution offers a clear advantage over conventional sutures and staples, supporting improved workflow and patient comfort across emergency medicine, surgical procedures, and general wound management.

A. Justin Lampropoulos, Chief Executive Officer of SYNDEO Medical, stated:

“The approvals in Saudi Arabia, Morocco, Brazil, and India represent a major step forward for our global expansion. Over the past year, we have worked strategically to secure registrations in highly influential markets that set standards for the regions around them. Clozex is an American made, world class technology that elevates how clinicians manage wounds and lacerations, and we are proud to make it available in multiple key geographies. These milestones reflect our commitment to delivering meaningful technologies that enhance patient care and empower outcomes worldwide.”

SYNDEO Medical will now begin phased commercial deployment of Clozex across Saudi Arabia, Morocco, Brazil, and India. This includes coordinated product availability, clinician education, and integration into hospitals, surgical centres, and emergency care networks in each respective market.